Login Register Cart 0
Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Hybrid Design of Isonicotinic Acid Hydrazide Derivatives: Machine Learning Studies, Synthesis and Biological Evaluation of their Antituberculosis Activity

Author(s): Vasyl Kovalishyn, Diana Hodyna, Vitaliy O. Sinenko, Volodymyr Blagodatny, Ivan Semenyuta, Sergiy R. Slivchuk, Volodymyr Brovarets, Gennady Poda* and Larysa Metelytsia

Volume 17, Issue 3, 2020

Page: [365 - 375] Pages: 11

DOI: 10.2174/1570163816666190411110331

Price: $65

Abstract

Background: Tuberculosis (TB) is an infection disease caused by Mycobacterium tuberculosis (Mtb) bacteria. One of the main causes of mortality from TB is the problem of Mtb resistance to known drugs.

Objective: The goal of this work is to identify potent small molecule anti-TB agents by machine learning, synthesis and biological evaluation.

Methods: The On-line Chemical Database and Modeling Environment (OCHEM) was used to build predictive machine learning models. Seven compounds were synthesized and tested in vitro for their antitubercular activity against H37Rv and resistant Mtb strains.

Results: A set of predictive models was built with OCHEM based on a set of previously synthesized isoniazid (INH) derivatives containing a thiazole core and tested against Mtb. The predictive ability of the models was tested by a 5-fold cross-validation, and resulted in balanced accuracies (BA) of 61–78% for the binary classifiers. Test set validation showed that the models could be instrumental in predicting anti- TB activity with a reasonable accuracy (with BA = 67–79 %) within the applicability domain. Seven designed compounds were synthesized and demonstrated activity against both the H37Rv and multidrugresistant (MDR) Mtb strains resistant to rifampicin and isoniazid. According to the acute toxicity evaluation in Daphnia magna neonates, six compounds were classified as moderately toxic (LD50 in the range of 10−100 mg/L) and one as practically harmless (LD50 in the range of 100−1000 mg/L).

Conclusion: The newly identified compounds may represent a starting point for further development of therapies against Mtb. The developed models are available online at OCHEM http://ochem.eu/article/11 1066 and can be used to virtually screen for potential compounds with anti-TB activity.

Keywords: Isonicotinic acid hydrazide derivatives, anti-tubercular activity, Mycobacterium tuberculosis, machine learning, online chemical database and modeling environment.

Graphical Abstract

[1]
Global tuberculosis report http://www.who.int/tb/ publications/global_report/en/2018
[2]
Martins F, Santos S, Ventura C, et al. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity. Eur J Med Chem 2014; 81: 119-38.
[http://dx.doi.org/10.1016/j.ejmech.2014.04.077] [PMID: 24836065]
[3]
Nandi S, Ahmed S, Saxena AK. Combinatorial design and virtual screening of potent anti-tubercular fluoroquinolone and isothiazoloquinolone compounds utilizing QSAR and pharmacophore modelling. SAR QSAR Environ Res 2018; 29(2): 151-70.
[http://dx.doi.org/10.1080/1062936X.2017.1419375] [PMID: 29347843]
[4]
Martins F, Ventura C, Santos S, Viveiros M. QSAR based design of new antitubercular compounds: improved isoniazid derivatives against multidrug-resistant TB. Curr Pharm Des 2014; 20(27): 4427-54.
[http://dx.doi.org/10.2174/1381612819666131118164434] [PMID: 24245762]
[5]
Ahamad S, Rahman S, Khan FI, et al. QSAR based therapeutic management of M. tuberculosis. Arch Pharm Res 2017; 40(6): 676-94.
[http://dx.doi.org/10.1007/s12272-017-0914-1] [PMID: 28456911]
[6]
Kovalishyn V, Brovarets V, Blagodatnyi V, et al. al. QSAR studies, synthesis and antibacterial assessment of new inhibitors against multidrug-resistant Mycobacterium tuberculosis. Curr Drug Discov Technol 2017; 14(1): 25-38.
[PMID: 27829331]
[7]
Soares A, Estevao MS, Marques MMB, et al. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents. Med Chem 2017; 13(5): 439-47.
[http://dx.doi.org/10.2174/1573406413666170209144003] [PMID: 28185538]
[8]
Kovalishyn V, Grouleff J, Semenyuta I, et al. Rational design of isonicotinic acid hydrazide derivatives with antitubercular activity: Machine learning, molecular docking, synthesis and biological testing. Chem Biol Drug Des 2018; 92(1): 1272-8.
[http://dx.doi.org/10.1111/cbdd.13188] [PMID: 29536635]
[9]
Siddiqui N, Arya SK, Ahsan W, Azad B. Diverse biological activities of Thiazoles: A retrospect. International Journal of Drug Development and Research 2011; 3: 55-67.
[10]
Shaikh MS, Palkar MB, Patel HM, et al. Design and synthesis of novel carbazolo-thiazoles as potential anti-mycobacterial agents using a molecular hybridization approach. RSC Advances 2014; 4: 62308-20.
[http://dx.doi.org/10.1039/C4RA11752B]
[11]
Sushko I, Novotarskyi S, Körner R, et al. Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information. J Comput Aided Mol Des 2011; 25(6): 533-54.
[http://dx.doi.org/10.1007/s10822-011-9440-2] [PMID: 21660515]
[12]
PubChem National Center for Biotechnology Information PubChem BioAssay Database https://pubchem.ncbi. nlm.nih.gov/bioassay/492952
[13]
Tetko IV. Associative neural network. Methods Mol Biol 2008; 458: 185-202.
[http://dx.doi.org/10.1007/978-1-60327-101-1_10] [PMID: 19065811]
[14]
Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting SystemArXiv e-prints 2016; 1603 arXiv:160302754
[http://dx.doi.org/10.1145/2939672.2939785]
[15]
Breiman L. Random forests. Mach Learn 2001; 45: 5-32.
[http://dx.doi.org/10.1023/A:1010933404324]
[16]
Hall LH, Kier LB. Electrotopological State Indexes for Atom Types - a Novel Combination of Electronic, Topological, and Valence State Information. J Chem Inf Comput Sci 1995; 35: 1039-45.
[http://dx.doi.org/10.1021/ci00028a014]
[17]
Tetko IV, Tanchuk VY, Kasheva TN, Villa AEP. Estimation of aqueous solubility of chemical compounds using E-state indices. J Chem Inf Comput Sci 2001; 41(6): 1488-93.
[http://dx.doi.org/10.1021/ci000392t] [PMID: 11749573]
[18]
Tetko IV, Tanchuk VY. Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program. J Chem Inf Comput Sci 2002; 42(5): 1136-45.
[http://dx.doi.org/10.1021/ci025515j] [PMID: 12377001]
[19]
ChemAxon - toolkits and desktop applications for chemoinformatics: Calculator Plugins http://www.chemaxon.com/marvin/help/ calculations/calculator-plugins.html(accessed February 1, 2016).
[20]
Todeschini R, Consonni V. Handbook of Molecular Descriptors. Weinheim: WILEY-VCH 2000.
[http://dx.doi.org/10.1002/9783527613106]
[21]
Whitley DC, Ford MG, Livingstone DJ. Unsupervised forward selection: a method for eliminating redundant variables. J Chem Inf Comput Sci 2000; 40(5): 1160-8.
[http://dx.doi.org/10.1021/ci000384c] [PMID: 11045809]
[22]
Tetko IV, Solov’ev VP, Antonov AV, et al. Benchmarking of linear and nonlinear approaches for quantitative structure-property relationship studies of metal complexation with ionophores. J Chem Inf Model 2006; 46(2): 808-19.
[http://dx.doi.org/10.1021/ci0504216] [PMID: 16563012]
[23]
Sushko I, Novotarskyi S, Körner R, et al. Applicability domain for in silico models to achieve accuracy of experimental measurements. J Chemometr 2010; 24: 202-8.
[http://dx.doi.org/10.1002/cem.1296]
[24]
Canetti G, Froman S, Grosset J, et al. Mycobacteria: Laboratory Methods for Testing Drug Sensitivity and Resistance. Bull World Health Organ 1963; 29: 565-78.
[PMID: 14102034]
[25]
Van Deun A, Aung KJ, Bola V, et al. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol 2013; 51(8): 2633-40.
[http://dx.doi.org/10.1128/JCM.00553-13] [PMID: 23761144]
[26]
Sushko I, Salmina E, Potemkin VA, Poda G, Tetko IV. ToxAlerts: a Web server of structural alerts for toxic chemicals and compounds with potential adverse reactions. J Chem Inf Model 2012; 52(8): 2310-6.
[http://dx.doi.org/10.1021/ci300245q] [PMID: 22876798]
[27]
Sinenko VO, Slivchuk SR, Mityukhin OP. Brovarets VS. Synthesis of New 1,3-Thiazolecarbaldehydes. Russ J Gen Chem 2017; 87: 2766-75.
[http://dx.doi.org/10.1134/S1070363217120039]
[28]
Sinenko V, Slivchuk S, Brovarets V. Lithiation of 2-bromo-4-(1,3-dioxolan-2-yl)-1,3-thiazole. Current Chemistry Letters 2018; 7: 1-8.
[http://dx.doi.org/10.5267/j.ccl.2018.1.002]
[29]
2014.Guidelines for the OECD Testing of Chemicals https://www.oecd.org/ env/ehs/testing/oecdguidelinesforthetestingofchemicals.htm
[30]
Hilbe JM. STATISTICA 7. Am Stat 2007; 61: 91-4.
[http://dx.doi.org/10.1198/000313007X172998]
[31]
Passino DRM, Smith SB. Acute bioassays and hazard evaluation of representative contaminants detected in Great Lakes fish. Environ Toxicol Chem 1987; 6: 901-7.
[http://dx.doi.org/10.1002/etc.5620061111]
[32]
Shaveta MS, Mishra S, Singh P. Hybrid molecules: The privileged scaffolds for various pharmaceuticals. Eur J Med Chem 2016; 124: 500-36.
[http://dx.doi.org/10.1016/j.ejmech.2016.08.039] [PMID: 27598238]
[33]
Hu YQ, Zhang S, Zhao F, et al. Isoniazid derivatives and their anti-tubercular activity. Eur J Med Chem 2017; 133: 255-67.
[http://dx.doi.org/10.1016/j.ejmech.2017.04.002] [PMID: 28390957]

Rights & Permissions Print Cite
Article Metrics
19
2
© 2024 Bentham Science Publishers | Privacy Policy